Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-03-03ClinicalTrials.gov study NCT00000391
-
CLINICAL_TRIALS study record update · 2015-03-03Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
-
CLINICAL_TRIALS study record update · 2015-03-02ClinicalTrials.gov study NCT00000393
-
CLINICAL_TRIALS study record update · 2015-02-27A Worldwide, Phase I, Dose-Escalating Study of Safety, Tolerability, and Immunogenicity of a 3-Dose Regimen of the MRKAd5 HIV-1 Gag Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2015-02-26Statin Therapy to Improve Inflammation and Atherosclerosis in HIV Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-02-23Pilot Study for the Evaluation of the Safety and the Feasibility of Treatment Simplification to Atazanavir/Ritonavir + Lamivudine in Patients Stably Treated With Two NRTIs + Atazanavir/Ritonavir With Optimal Virologic Response.
-
CLINICAL_TRIALS study record update · 2015-02-23Effect of Vicriviroc on HIV RNA Levels in Cerebrospinal Fluid
-
CLINICAL_TRIALS study record update · 2015-02-16Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2015-02-10Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2015-02-06Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects
-
CLINICAL_TRIALS study record update · 2015-02-05COVER - Continuing Observation After Vicriviroc (VCV) Exposure Registry
-
CLINICAL_TRIALS study record update · 2015-02-04Phase IIb Pilot Study for the Evaluation of the Safety and the Feasibility of Treatment Simplification to Tenofovir+Emtricitabine+Raltegravir or to Lamivudine+Abacavir+Raltegravir in Patients With Optimal Virological Control and Toxicity to the Current Combined Antiretroviral Regimen
-
CLINICAL_TRIALS study record update · 2015-01-29Pilot Study of the Effect of Low-Dose Rosuvastatin on Endothelial Function, Oxidative Stress and Inflammatory Parameters in HIV-Infected Individuals With Low HDL Cholesterol Levels and Low to Normal LDL Cholesterol Levels
-
CLINICAL_TRIALS study record update · 2015-01-27Phase I, Open, Sequential Vaccination Study on Safety and Tolerability of Two Different Doses of a Recombinant MVA HIV Polytope Vaccine (MVA-mBN32) in HIV-negative 18-50 Year Old Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2015-01-27A Randomized, Open-label Study Evaluating the Antiviral Activity and Safety of 3 Month Fuzeon Induction With an Optimized Background Antiretroviral Regimen Versus OB Alone, in Fuzeon-naive HIV-1 Infected Patients With Virological Failure.
-
CLINICAL_TRIALS study record update · 2015-01-26A Phase 3B Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination (FTC/TDF) to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate (EVG/COBI/FTC/TDF) Single-Tablet Regimen (STR) in Virologically Suppressed, HIV-1 Infected Patients
-
CLINICAL_TRIALS study record update · 2015-01-26RCT of Stepping Stones Behavioural Intervention for HIV
-
CLINICAL_TRIALS study record update · 2015-01-26A Phase 3b Randomized, Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Plus Emtricitabine (FTC) and Tenofovir DF (TDF) to the Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (EVG/COBI/FTC/TDF) in Virologically Suppressed, HIV 1 Infected Patients
-
CLINICAL_TRIALS study record update · 2015-01-26A Phase 3b Randomized, Open-Label Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI + RTV) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (EVG/COBI/FTC/TDF) in Virologically-Suppressed, HIV-1 Infected Patients
-
CLINICAL_TRIALS study record update · 2015-01-21Improving Uptake of Early Infant Diagnosis of HIV for PMTCT: a Randomized Trial of a Text Messaging Intervention
-
CLINICAL_TRIALS study record update · 2015-01-21Non-interventional Observational Study With Viramune® Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data.
-
CLINICAL_TRIALS study record update · 2015-01-16A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS
-
CLINICAL_TRIALS study record update · 2015-01-16Text Messaging to Improve Adherence to Post-Operative Clinic Appointments and Reduce Early Resumption of Sexual Intercourse After Adult Male Circumcision: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2015-01-16A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients With CD4 Counts <= 100 Cells/mm3
-
CLINICAL_TRIALS study record update · 2015-01-16HIV-Associated Cognitive Impairment and Oxidative Stress: An In Vivo Proton Magnetic Resonance Spectroscopy Study of Cerebral Injury